Leon Cooperman's Omega Advisors Sells Apple, Gilead; Buys Humana, GM And IBM

In the hedge fund’s latest 13-F filing, Omega Advisors and CEO Leon Cooperman disclosed changes to the fund’s holdings that occurred during Q1 of 2015.

Here’s a list of some of the moves the fund made to its largest positions during the quarter.

Buys

  • Acquired position in General Motors Company GM totaling 1,839,423 shares
  • Acquired position in Dow Chemical Co DOW totaling 1,873,900 shares
  • Acquired position in Mobileye NV MBLY totaling 150,000 shares
  • Acquired position in Humana Inc HUM totaling 593,400 shares
  • Acquired position in International Business Machines Corp. IBM totaling 333,067 shares
  • Acquired position in Oasis Petroleum Inc. OAS totaling 420,500 shares
  • Acquired position in Sears Holdings Corp SHLD totaling 868,752 shares

Increases

  • Increased position in AerCap Holdings N.V. AER by 120,277 shares
  • Increased position in Melco Crown Entertainment Ltd MPEL by 1,033,500 shares
  • Increased position in Kinder Morgan Inc KMI by 1,912,629 shares
  • Increased position in Chimera Investment Corporation CIM by 10,426,336 shares
  • Increased position in Citigroup Inc C by 55,200 shares

Reductions

  • Reduced position in Actavis Plc ACT by 10,097 shares
  • Reduced position in American International Group Inc AIG by 137,700 shares
  • Reduced position in Ashland Inc ASH by 52,300 shares
  • Reduced position in Caesars Entertainment Corp CZR by 483,519 shares

Liquidations

  • Liquidated position in Apple Inc. AAPL
  • Liquidated position in Gilead Sciences, Inc. GILD
  • Liquidated position in GrubHub Inc GRUB
  • Liquidated position in Ally Financial Inc ALLY

These changes to Omega’s holdings that occurred during Q4 are merely some of the many adjustments the fund made to its portfolio. The fund’s full 13-F filing can be found here.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!